View multimedia presentations delivered by our internal experts and renowned external leaders

Educational Video Shorts

Longitudinal Course of ADHD

12 min

Longitudinal Course of ADHD
Longitudinal Course of ADHD video play button
Longitudinal Course of ADHD
  • Video Chapters +
    1. Introduction
    2. Longitudinal Course of ADHD Overview
    3. ADHD & Early Life/Preschool
    4. ADHD & School Age
    5. ADHD & Adolescence/Adulthood
    6. Long-term Outcomes & Treatment
  • Description +

    Do you think about ADHD as a lifelong disorder? Watch this video for a brief look into how the clinical manifestation, etiology, and pathophysiology change from childhood through adulthood and from school to the workplace as well as how treatment impacts long-term functional outcomes.

  • Speaker Bio +

    Dr. Dansie began a career focused on CNS and neurodevelopmental disorders in 2006. She began her career in the pharmaceutical industry as a Medical Science Liaison (MSL) in 2015. Since 2018, her sole professional focus has been on ADHD. Dr. Dansie joined Tris Pharma in 2019, and she is currently Director, Field Medical Strategy. In addition to retaining some traditional MSL activities, her current responsibilities are centered on informing medical operations and strategy, including support of company strategy, as well as evaluation and development of digital platforms and opportunities. She also guest lectures for Neuroscience courses at the University of California, Riverside (UCR) as well as serves as a speaker and mentor for various career development programs throughout the country. She received her PhD in Biochemistry and Molecular Biology from UCR for laboratory, behavioral, clinical and translational research she participated in studying Fragile X Syndrome. Following completion of her PhD she completed a postdoctoral fellowship at St. Jude’s Children’s Research Hospital while concurrently completing her MBA at the University of Memphis.

Etiology & Pathophysiology of ADHD

10.5 min

Etiology & Pathophysiology of ADHD
Etiology & Pathophysiology of ADHD video play button
Etiology & Pathophysiology of ADHD
  • Video Chapters +
    1. Introduction
    2. Genetic Factors
    3. Environmental Factors
    4. Heritability in Families
    5. Structural Differences
    6. Functional Differences
    7. Network Differences
    8. Persistent vs. Remitted
    9. Intermittent Remission
    10. Feedback Survey
  • Description +

    Ever had questions about the cause of ADHD? Watch this video for a brief introduction into the causality and neurobiology of ADHD, touching on genetic and environmental factors, structural and functional differences, as well as persistent vs. remitted ADHD.

  • Speaker Bio +

    Dr. Dansie began a career focused on CNS and neurodevelopmental disorders in 2006. She began her career in the pharmaceutical industry as a Medical Science Liaison (MSL) in 2015. Since 2018, her sole professional focus has been on ADHD. Dr. Dansie joined Tris Pharma in 2019, and she is currently Director, Field Medical Strategy. In addition to retaining some traditional MSL activities, her current responsibilities are centered on informing medical operations and strategy, including support of company strategy, as well as evaluation and development of digital platforms and opportunities. She also guest lectures for Neuroscience courses at the University of California, Riverside (UCR) as well as serves as a speaker and mentor for various career development programs throughout the country. She received her PhD in Biochemistry and Molecular Biology from UCR for laboratory, behavioral, clinical and translational research she participated in studying Fragile X Syndrome. Following completion of her PhD she completed a postdoctoral fellowship at St. Jude’s Children’s Research Hospital while concurrently completing her MBA at the University of Memphis.

History & Prevalence of ADHD in Adults

5.5 min

History & Prevalence of ADHD in Adults
History & Prevalence of ADHD in Adults video play button
History & Prevalence of ADHD in Adults
  • Video Chapters +
    1. Introduction
    2. Evolution of ADHD Diagnosis
    3. What is ADHD?
    4. Complication of Adult ADHD
    5. Prevalence of Adult ADHD
    6. Survey
  • Description +

    How much do you know about the evolution of what we know today as ADHD? Watch this video for a quick history on our understanding of ADHD and the evolution of the DSM criteria as well as learn what we know about the prevalence of ADHD in various adult populations.

  • Speaker Bio +

    Dr. Dansie began a career focused on CNS and neurodevelopmental disorders in 2006. She began her career in the pharmaceutical industry as a Medical Science Liaison (MSL) in 2015. Since 2018, her sole professional focus has been on ADHD. Dr. Dansie joined Tris Pharma in 2019, and she is currently Director, Field Medical Strategy. In addition to retaining some traditional MSL activities, her current responsibilities are centered on informing medical operations and strategy, including support of company strategy, as well as evaluation and development of digital platforms and opportunities. She also guest lectures for Neuroscience courses at the University of California, Riverside (UCR) as well as serves as a speaker and mentor for various career development programs throughout the country. She received her PhD in Biochemistry and Molecular Biology from UCR for laboratory, behavioral, clinical and translational research she participated in studying Fragile X Syndrome. Following completion of her PhD she completed a postdoctoral fellowship at St. Jude’s Children’s Research Hospital while concurrently completing her MBA at the University of Memphis.

Diagnosis & Screening for ADHD in Adults

3.5 min

Diagnosis & Screening for ADHD in Adults
Diagnosis & Screening for ADHD in Adults video play button
Diagnosis & Screening for ADHD in Adults
  • Video Chapters +
    1. Introduction
    2. DSM-5 – ADHD Symptoms in Adults
    3. DSM-5 – ADHD Diagnostic Criteria in Adults
    4. Screening of ADHD in Adults
    5. Adult ADHD Rating Scales: Validated Symptom Scales
  • Description +

    Did you know that the DSM-5 diagnostic criteria for ADHD are different for adults and children? Watch this video for a quick overview of the symptoms and diagnosis in adult ADHD. You will also learn about screening and evaluation scales used in your ADHD assessments.

  • Speaker Bio +

    Dr. Everitt is a former Director, Field Medical Strategy for Tris Pharma. Her professional experience in CNS disorders began in 2008, which focused on ADHD, depression, bipolar disorder, and schizophrenia.

    Previously, Dr. Everitt served as co-chief in a 2-year Global Medical Neuroscience Fellowship at Rutgers University. As adjunct faculty at Rutgers University College of Pharmacy, Dr. Everitt co-coordinated and taught Advanced Neuropsychiatry and Community Pharmacy Management.

    She received her PharmD from Nova Southeastern University and earned her postdoctoral MS in Clinical Psychopharmacology at Fairleigh Dickinson University.

Expert webinar recordings

Diagnosing ADHD in Adults: Why is it so Challenging?

55 min

Diagnosing ADHD in Adults: Why is it so Challenging?
Diagnosing ADHD in Adults: Why is it so Challenging? video play button
Diagnosing ADHD in Adults: Why is it so Challenging?
  • Video Chapters +
    1. Learning Objectives
    2. ADHD Genetics & Environment
    3. ADHD Brain Structure & Function
    4. ADHD Across the Lifespan
    5. Development Phases & Trends
    6. DSM-5 Criteria for ADHD
    7. Transition of Care Adolescent to Adult
    8. Why is Adult ADHD Missed
    9. How does Adult ADHD Present
    10. Comorbidities & IQ in Adult ADHD
    11. Remission, Recovery & Persistence
    12. Functional Impairments & Mortality
    13. Diagnosis of Adult ADHD
    14. Best Practices for Management
    15. Summary
  • Description +

    Diagnosing ADHD in adults brings substantially different considerations and challenges than it does for making the diagnosis in children. Renowned primary care psychiatry clinician, Dr. Brendan Montano guides you through the developmental trajectory of ADHD and patterns of impairments throughout the lifespan to better understand the clinical presentations and challenges of ADHD in adults.
    This video is a recorded version of an educational webinar intended for health care professionals (HCPs). The content of the video, including but not limited to, the opinions expressed by the presenter, is solely that of the presenter. Tris Pharma, Inc. (Tris) had no control of the content or opinions expressed, with the exception to confirm that this educational webinar conforms to FDA regulations for communications with HCPs, other applicable laws, and Tris Guidelines for communications with HCPs. Tris did not seek to edit, guide, or influence content beyond ensuring, prior to the educational webinar, that this educational webinar conforms with controlling FDA regulations. Nothing contained herein should be considered a solicitation, promotion or advertisement for any Tris drug, including those under development. Any information contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by a physician or other HCP.

  • Speaker Bio +

    Dr. Montano is Director and Principal Investigator for CT Clinical Research in Cromwell, Connecticut, where he also holds a private practice in internal medicine, specializing in preventative medicine and mood disorders. In addition, he is an attending physician at Middlesex Hospital in Middletown, Connecticut.
    Dr. Montano received his medical degree at the Albany Medical College of Albany, New York. He completed his residency in internal medicine at St. Francis Hospital and Medical Center in Hartford, Connecticut, and then trained as a resident in neurology, gastroenterology, and dermatology at Yale University in New Haven, Connecticut.

Advances in the Genetics of ADHD: Implications for Clinicians

39 min

Advances in the Genetics of ADHD: Implications for Clinicians
Advances in the Genetics of ADHD: Implications for Clinicians video play button
Advances in the Genetics of ADHD: Implications for Clinicians

What am I Missing in Adults with ADHD?

65 min

What am I Missing in Adults with ADHD?
What am I Missing in Adults with ADHD? video play button
What am I Missing in Adults with ADHD?

Telemedicine: Providing Care Without Geographic Limits During COVID

31 min

telemedicine
Telemedicine: Providing Care Without Geographic Limits During COVID
Telemedicine: Providing Care Without Geographic Limits During COVID video play button
Telemedicine: Providing Care Without Geographic Limits During COVID
  • Video Chapters +
    1. Introduction
    2. Robert Caudill, MD
    3. In-Person vs. Telehealth
    4. Virtual Environment: What’s Lost?
    5. Patient Selection
    6. Past Barriers to Telemedicine
    7. Current Barriers and Future of Telemedicine
    8. Jon Evans, MS
    9. Support for Telepsychiatry: Growing Need
    10. Advantages of Telepsychiatry
    11. Keys to Adopting/Expanding Telehealth
    12. Tips for Integrating into Existing Workflow
    13. CMS Regulatory Changes
    14. Temporary Waiver of Ryan Height Act
  • Description +

    COVID-19 led to significant changes in the way patient care is delivered and received. Join two telehealth experts as they provide their practical experience around the use and integration of telemedicine.

    This video is a recorded version of an educational webinar intended for health care professionals (HCPs). The content of the video, including but not limited to, the opinions expressed by the presenter, is solely that of the presenter. Tris Pharma, Inc. (Tris) had no control of the content or opinions expressed, with the exception to confirm that this educational webinar conforms to FDA regulations for communications with HCPs, other applicable laws, and Tris Guidelines for communications with HCPs. Tris did not seek to edit, guide, or influence content beyond ensuring, prior to the educational webinar, that this educational webinar conforms with controlling FDA regulations. Nothing contained herein should be considered a solicitation, promotion or advertisement for any Tris drug, including those under development. Any information contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by a physician or other HCP.

  • Speaker Bio +

    Dr. Robert Caudill is a Professor of Psychiatry at the University of Louisville. He is the Residency Training Director with an interest in optimizing the role of technology in post-graduate medical education. He is also Director of Telemedicine and Information Technology Programs for the Department of Psychiatry. Dr. Caudill is a past chair for the Telemental Health Special Interest Group of the American Telemedicine Association and fellow in that organization. He is co-chair of the Telehealth Task Group of the National Network of Depression Centers. He is a distinguished fellow of the American Psychiatric Association and a founding member of its Committee on Telepsychiatry. Dr. Caudill completed his internship and psychiatric residency at the University of Louisville where he was a Chief Resident, President of the Psychiatric Residents’ Association and recipient of the department’s Award for Academic Excellence. Dr. Caudill received his board certification in psychiatry in 1995. He lectures on a number of topics related to technology, psychosocial rehabilitation, and psychopharmacology. Along with his faculty appointment, Dr. Caudill has served as a staff psychiatrist with several community mental health agencies in Kentucky.

    Mr. Jon Evans received his Masters Degree in Clinical Psychology from Edinboro University of Pennsylvania and has been employed in the behavioral healthcare field for over 30 years. His career began at Hamot Institute for Behavioral Health where he was initially employed in the emergency department providing initial evaluations for patients presenting in the emergency room. In 1993, Mr. Evans became the founding President and CEO of Safe Harbor Behavioral Health. Safe Harbor was established to provide intensive outpatient services to patients with serious mental illness and to provide 24 hour a day crisis intervention services to anyone in Erie County. Through a SAMSHA Grant, Mr. Evans initiated and implemented a full time Tele-Psychiatry program at Safe Harbor Behavioral Health successfully enhancing access to care in the outpatient clinic. As a result of the successful implementation and patient outcomes, Mr. Evans founded InnovaTel Telepsychiatry in 2014 providing telepsychiatry coverage in multiple states in partnership with community provider organizations. Recently, the InnovaTel Telepsychiatry was endorsed as the premiere provider by National Council of Behavioral Health.

Clinical Video Shorts

Clinical Trials: Overview & Terminology

6.5 min

Clinical Trials: Overview & Terminology
Clinical Trials: Overview & Terminology video play button
Clinical Trials: Overview & Terminology
  • Video Chapters +
    1. Introduction
    2. Phase 1
    3. Phase 2
    4. Phase 3
    5. Phase 4
  • Description +

    Are you aware of the clinical trials that must be conducted before and after a pharmaceutical is FDA-approved? Watch this video for a quick overview of the four phases of clinical trials.

  • Speaker Bio +

    Dr. Everitt is a former Director, Field Medical Strategy for Tris Pharma. Her professional experience in CNS disorders began in 2008, which focused on ADHD, depression, bipolar disorder, and schizophrenia.

    Previously, Dr. Everitt served as co-chief in a 2-year Global Medical Neuroscience Fellowship at Rutgers University. As adjunct faculty at Rutgers University College of Pharmacy, Dr. Everitt co-coordinated and taught Advanced Neuropsychiatry and Community Pharmacy Management.

    She received her PharmD from Nova Southeastern University and earned her postdoctoral MS in Clinical Psychopharmacology at Fairleigh Dickinson University.